Clin2
NCT03915262Possibly a fitRecruiting

Active Crohn’s patients with possible pancreas enzyme problems

Crohn Disease

Part of Digestive system clinical trials.

This study looks at how often people with active Crohn’s disease also have trouble digesting food because the pancreas may not release enough enzymes (exocrine pancreatic insufficiency). It may help doctors better recognize this hidden problem in people whose Crohn’s is currently active.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years and older
Study type
Observational

Who can take part

  • You are 18 or older.
  • You have Crohn’s disease that has been diagnosed for more than 3 months.
  • Your Crohn’s is considered “active” based on symptoms plus at least one test result (like blood inflammation markers, stool inflammation, or scans/endoscopy findings).
  • Your doctor is planning or indicates a biologic treatment (anti-TNF, vedolizumab, or ustekinumab).
  • You have not had chronic pancreatitis diagnosed before joining.
  • You are not currently taking pancreatic enzyme replacement and you can safely take the planned biologic treatment.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06494826Recruiting
Study of gut bacteria and proteins in new Crohn's disease patients

This study looks at proteins from your body and gut bacteria to understand Crohn's disease better. You may join if you are about to have your first colonoscopy for suspected Crohn's and have not had any treatment yet.

Afula
NCT04946448Recruiting
Test a Crohn’s diet and biologic medicine combination

This study tests whether combining a specific diet with biologic medicines can reduce active inflammation and symptoms of Crohn’s disease. It may help people who still have active disease in the bowel despite prior care.

Leuven
NCT04973423Recruiting
Testing extra check-ins for Crohn’s using stool tests and MRI

This study checks whether adding an extra, cross-body “transmural” evaluation (looking at inflammation throughout the bowel) improves care for adults with Crohn’s who are starting or receiving biologic (biotherapy) treatment. It uses close follow-up with stool calprotectin (a marker of gut inflammation) to see if this approach helps control inflammation.

Amiens
NCT06882993Recruiting
Testing a gentler approach to diagnose Crohn's disease

This trial tests a new, gentler way to diagnose Crohn's disease. If you have symptoms like long-lasting diarrhea or belly pain, this study may help find out if you have Crohn's without invasive procedures.

Esbjerg
NCT05824403Recruiting
Pancreas disease study for non-cancer patients

This study follows people with certain inflammatory or cyst-related pancreas conditions to learn more about their health and outcomes. It may help improve understanding of these pancreas problems and guide better care.

Toulouse
NCT07559175Not yet recruiting· Phase 2
New Pancreatic Enzyme Treatment for Adults With Pancreatic Insufficiency

This study tests a new digestive enzyme supplement (NHS7108) in adults whose pancreas doesn't make enough enzymes to digest food properly. The trial evaluates whether this new treatment is safe and helps improve fat digestion better than current treatments.

Scottsdale, Arizona

Hear when a new Crohn Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.